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Background. Breast cancer survival has improved significantly in the US in the past 10–15 years. However, disparities exist in breast
cancer survival between black and white women. Purpose. To investigate the effect of county healthcare resources and SES as well as
individual SES status on breast cancer survival disparities between black and white women.Methods.Data from 1,796 breast cancer
cases were obtained from the Surveillance Epidemiology and End Results and the National Longitudinal Mortality Study dataset.
Cox Proportional Hazards models were constructed accounting for clustering within counties. Three sequential Cox models were
fit for each outcome including demographic variables; demographic and clinical variables; and finally demographic, clinical, and
county-level variables. Results. In unadjusted analysis, black women had a 53% higher likelihood of dying of breast cancer and 32%
higher likelihood of dying of any cause (𝑃 < 0.05) compared with white women. Adjusting for demographic variables explained
away the effect of race on breast cancer survival (HR, 1.40; 95% CI, 0.99–1.97), but not on all-cause mortality. The racial difference
in all-cause survival disappeared only after adjusting for county-level variables (HR, 1.27; CI, 0.95–1.71). Conclusions. Improving
equitable access to healthcare for all women in the US may help eliminate survival disparities between racial and socioeconomic
groups.
1. Introduction
Breast cancer incidence and mortality rates have declined
steadily in theUS for the past 10–15 years [1–7].The relative 5-
year survival rate for breast cancer overall has also increased
in the past decade to 89% [8]. Unfortunately, disparities exist
in breast cancer outcomes between racial groups in the US.
Although survival has increased for both white and black
women over time, the survival increase in black women has
been smaller [2]. Five-year relative survival for breast cancer
was 90% for white women and 77% for black women between
2001 and 2007 [8, 9]. Several reasons have been suggested
for the survival disparity between black and white women,
including racial differences in access to and utilization of
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screening and treatment [10–12], risk factors that are differen-
tially distributed by race [10, 13–15] and socioeconomic status
(SES) [14, 16–20], and biological differences such as tumor
aggressiveness [21, 22].
The results of research studies assessing the role of SES
in racial disparities in breast cancer survival are mixed; some
studies reported that racial differences in survival disappear
after adjusting for SES [17, 19, 20, 23, 24], while other studies
show survival differences persisting after adjustment for SES
[13, 14, 17, 20, 25–27]. The conflicting results may be due to
the lack of SES information in cancer registries in the US,
resulting in insufficient characterization of socioeconomic
levels of patients [11, 20, 25, 28]. In addition to SES, differential
levels of healthcare resources at the neighborhood level
have also been examined in previous studies as potentially
contributing to racial disparities in cancer outcomes [29–36].
However, the same limitations exist as with studies of SES
effect on racial disparities in breast cancer survival—lack of
consistency in which measure of health care resources to use
and questions about which geographic level neighborhood
differences are measured.
Defining healthcare access is complicated, mainly
because the construct encompasses dimensions of healthcare
availability, affordability, acceptability, and accessibility.
To ensure that valid inferences are drawn, it is necessary
to specify which aspect of healthcare access is being
measured. For this study, we focused on the availability
of healthcare resources at the county level as our measure
of healthcare access. To our knowledge, no other research
study has developed a specific measure of neighborhood
healthcare access as a predictor of breast cancer survival
among blacks and whites in the US, while controlling for
individual and neighborhood level SES.This is unique. Other
studies attempting to examine the impact of neighborhood
effects on breast cancer survival have done so without
individual level SES data [26] or did not simultaneously
control for healthcare resource availability. The aim of this
study was to assess the impact of neighborhood health
care resources on white-black disparities in breast cancer
survival by adjusting for individual and neighborhood
SES.
2. Methods
2.1. Data Sources and Analytic Samples. This study utilized
the National Cancer Institute’s Surveillance Epidemiology
and End Results data linked to the US Census Bureau’s
National Longitudinal Mortality Study database (NLMS).
The linked dataset is referred to in this study as (SEER-
NLMS). Detailed methodology regarding this dataset has
been published elsewhere [13, 37, 38]. In brief, SEER data
on cancer incidence, prevalence and survival from 15 partic-
ipating registries, covering about 25% of the US population
[39] was linked with the NLMS data to capture demographic,
socioeconomic, and occupation attributes from the Current
Population Surveys and the Annual Social and Economic
Supplement [38]. A full description of the NLMS is available
at the census website (http:/www.census.gov/nlms/).
Data on county level SES, health care facilities, and
health care personnel were obtained from the 2009-2010
Area Resource File [40] which contains over 6,000 variables
relating to healthcare, socioeconomic, and environmental
characteristics for each county in theUS. Data on the number
of certified mammography facilities was obtained through a
Freedom of Information (FOI) request to the Food and Drug
Administration (FDA), the agency in charge of certifications
[41]. A list and addresses of all mammography facilities
certified in the year 2000 was provided by the FDA. The
dataset used in the final analysis was restricted to non-
Hispanic black and non-Hispanic white first primary breast
cancer cases among women with ages 40 years and older,
diagnosed between 1973 and 2003.The analysis was restricted
to non-Hispanic black and white women to facilitate the
comparison of two racial groups in the US that have shown
sustained and consistently high disparities in breast cancer
survival. A total of 3511 women fulfilled this criterion: 3283
whites and 228 blacks. We focused the main analysis on
women residing in counties that contained at least one black
and one white breast cancer patient to ensure that the neigh-
borhood level predictors represented the actual experiences
of both groups of women. A total of 1796 women met this
criterion: 1580 whites and 216 blacks residing in 60 counties
in the US. A flowchart describing the sample selection is
available as a supplemental figure in supplementarymaterials
available at http://dx.doi.org/10.1155/2013/490472. Counties
were identified using the Federal Information Processing
Standard (FIPS) code [42] to link county variables with cases’
county of residence at diagnosis as recorded in the SEER
dataset.
2.2. Data Management: Sociodemographic Variables. Race
was categorized as non-Hispanic white and non-Hispanic
black. Marital status was categorized as married, widowed,
divorced/separated, and never married. Employment status
was categorized as women in the labor force and women
not in the labor force. Education level was categorized as
less than high school (<12 years), high school graduate (12
years), and at least some college (≥13 years). Age at diagnosis
and income were analyzed as continuous variables; income
was analyzed as inflation-adjusted annual household income
(1990 standard).
Clinical Variables. Stage at presentation was categorized as
in situ/localized, regional, and distant/unstaged. Surgical
treatment was categorized as surgical treatment received, not
received due to medical reasons, and not received due to
nonmedical reasons. Radiation treatment was also catego-
rized as received, not received due to medical reasons, and
not received due to nonmedical reasons. Surgical or radiation
treatment not received due to nonmedical reasons included
those that were recommended but not performed, recom-
mended and it was unknown if performed, or treatment
information was unknown due to death certificate or autopsy
diagnosis.
Survival. Survival time was calculated as the number of
months between diagnosis and either date of death, date last
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known to be alive, or December 31, 2003. We created two
censoring variables based on SEER cause of death variable:
one that indicated if a person had died with breast cancer as
the underlying cause, and the other that indicated if a person
had died of any cause. Patients who died of other causes or
were alive at the date of last followupwere censored in the first
censoring variable, and patients who were alive at the date of
last followup were censored in the second censoring variable
[13].
Health Care Access Variables. Health care access was defined
as the linear combination ofmeasures of density of health care
resources in the county [32]. We assessed specific variables
related to health care resources at the county level and
adjusted for differences in population size by dividing the
counts per 10,000 people in each county. The derived vari-
ables were subject to principal component analysis (PCA) on
count per 10,000 of number of hospitals, number of medical
doctors, number of medical doctors with obstetrics and
gynecology specialty, number of Osteopathic Doctors (DO),
number of DOs with obstetrics and gynecology specialty,
number of nurse practitioners, and number of mammogra-
phy facilities. SAS Proc Factor was used to generate scores
using an eigenequation [43] based on our input variables.The
scores were categorized into tertiles: poorest, middle, and
highest.
Socioeconomic Status Variables. County level SES was defined
using the index of concentration in the extremes (ICE).
This index was chosen over other approaches (such as the
proportion of county residents below poverty level) because
it allows for conceptualizing the concentration of affluence
and disadvantage as falling along a single continuum. The
index theoretically ranges from −1 (where all households are
disadvantaged) through 0 (where there is equal proportion
of affluent and disadvantaged households) to +1 (where all
households are affluent) [44]. Two ICE indices were created:
income based and education based.
ICE-Income = ((# households with household income,
$100,000+) − (# households with families below poverty
level)/total number of households).
ICE-Education = ((% persons 25 years+ with 4+ yrs
college) − (% persons 25 years+ with <9 yrs sch)/100).
For easy interpretation, these measures were also catego-
rized into tertiles. To control for other county level variables
that may be associated with income, we included county level
proportion of blacks and percent non-English speaking [36].
County Variables. All county level variables were obtained
from the Area Resource File for the year 2000 because it
had the most complete year of data and straddled the years
included in the SEER dataset. We compared scores for 1990
and 2000 and found them to be highly correlated (ICE
income correlation coefficient = 0.90, 𝑃 < 0.05 and ICE
education correlation coefficient = 0.94, 𝑃 < 0.05). There
were 3141 counties available for the county level analysis of
health care access and SES. The first two components of the
PCA had eigenvalues greater than 1, and the scree test also
showed a clear break after the second component (figure
not shown). Therefore, only the first two components were
retained for further analysis. The two components together
accounted for 50.5% of the total variance; components that
had a factor loading value of greater than 0.4were said to have
loaded on a specific component. Based on this criterion,MDs
per 10,000, MDs in Ob-Gyn per 10,000, nurse practitioners
per 10,000, and DOs per 10,000 were loaded on the first
component, hereafter named personnel. Number of hospitals
per 10,000 and number ofmammography facilities per 10,000
were loaded on the second component, hereafter named
facilities. ICE-Income and ICE-Education scores were also
calculated per county.
3. Statistical Analysis
All statistical analyses were performed using SAS statistical
software (SAS, Version 9.2). The analysis was weighted
according to the US population size during the study period.
Descriptive statistics were generated using chi-square statis-
tics and 𝑡-tests.Multivariable proportional hazards regression
was used to model the hazards of breast cancer and all-cause
mortality in three separate models. The first model adjusted
for demographic variables, the second model included clin-
ical variables regarding stage of presentation and treatment,
and the third model included county level variables. Robust
sandwich estimates for the covariance matrix were used to
account for the clustering of cases within counties, and the
county FIPS code was specified as the clustering variable.
4. Results
Table 1 provides information on the distribution of county
variables relating to healthcare resources, socioeconomic
status, and other controls across the US.
Table 2 illustrates the distribution of demographic, clin-
ical, and county level variables. On average, black patients
were about 2 years younger compared with white patients,
had a lower annual household income ($25,000 for blacks
versus $44,700 for whites), were more likely to be single
(19.1% of blacks versus 7.4% of whites) and divorced (19.7% of
blacks versus 9.8% of whites), and were more likely to have
less than a high school education (23.6% of blacks versus
9.5% of whites). The distribution of stage at diagnosis was
similar between blacks and whites; about 53% of blacks were
diagnosed at in situ/localized stage compared with 54.6%
of white cases, and 14.2% of blacks were distant/unstaged
compared with 13.3% of white cases. Black patients were also
less likely to have received surgical (91% of blacks versus 95%
of whites) and radiation treatment (31% of blacks versus 39%
of whites) compared with white patients.
At the county level, black patients were more likely than
white patients to live in counties that had a higher proportion
of households in poverty (36.9% of blacks versus 16.8% of
whites), higher proportion of adults with less than 9 years
of education (43.2% of blacks versus 26.9% of whites), and
higher proportion of blacks (87.5% of blacks versus 67.5% of
whites). Whites were more likely to reside in counties with
the poorest healthcare facilities (38.1% of whites versus 32.7
4 Journal of Cancer Epidemiology
Table 1: Descriptive statistics of healthcare access and socio-economic characteristics of 3141 US counties in 2000-2001, Area Resource File
2009-2010.
Variable All US counties (𝑛 = 3141) Analysis counties (𝑛 = 60)
Mean Std Dev Min Max Mean Std Dev Min Max
County level health care access
aPersonnel −2.058𝐸 − 16 1.000 −1.519 13.777 0.814 0.866 −0.819 3.054
aFacilities −1.968𝐸 − 16 1.000 −2.565 10.801 −0.482 0.316 −1.014 0.605
County level income and education
bIndex of concentration at the extremes (Income) −0.009 0.076 −0.429 0.358 0.067 0.098 −0.168 0.359
bIndex of concentration at the extremes (Education) 0.074 0.114 −0.394 0.619 0.160 0.122 −0.137 0.390
County level controls
% Non-English speaking 1.631 2.610 0 28.715 4.970 4.405 0 15.889
% Black 8.763 14.512 0 86.500 16.06 15.49 0.300 67.300
a
Personnel and facilities, two measures of health care access were defined using principal components analysis on the count per 10,000 population of county
level variables. Facilities: hospitals, mammography facilities; Personnel: MDs, Dos, and nurse practitioners.
bMeasures of SES at the county level are the ICE-Income and ICE-Education variables, defined as
ICE-Education = (% 25+ years with college degree −% 25+ years with <9 yrs education).
ICE-Income = (% with HH income > $100,000 −%HH in poverty).
of blacks) and a higher proportion of non-English speaking
residents (77.6% of whites versus 59.7% of blacks). All of these
differences were statistically significant at the 𝑃 < 0.05 level.
In unadjusted analysis (Tables 3 and 4), black women had
a 53% higher likelihood of dying of breast cancer (𝑃 = 0.008)
and 32% higher likelihood of dying of any cause (𝑃 = 0.02)
compared with white women. Having less than high school
education increased the likelihood of breast cancer mortality
by 68%, and all-cause mortality by 95%. Furthermore, being
diagnosed at a distant stage and not receiving surgical or
radiation treatment was also associated with significantly
higher likelihood of death.
Table 3 also presents the results of three sequential Cox
Proportional Hazards multivariable models assessing the
determinants of breast cancer survival. Model 1 assessed the
effect of race on breast cancer mortality after adjusting for
demographic variables. Race was no longer a statistically
significant predictor of breast cancer death after adjusting
for the individual variables (hazard ratio, 1.40; 95% CI, 0.99–
1.97). Model 2 adjusted additionally for stage at presentation
and treatment, and the effect of race remained nonsignif-
icant. Model 3 presents the effect of county level variables
adjusting for individual demographic and clinical variables
on breast cancer mortality. Residing in counties with a
higher proportion of households in poverty increased the
likelihood of breast cancer deaths compared with counties
with a higher proportion of affluent households. The hazard
ratio of ICE-Income comparing the poorest versus highest
groupwas 1.29 (95%CI, 0.82–2.05) and comparing themiddle
versus highest group was 1.49 (95% CI, 1.12–1.99). On the
other hand, residing in counties with a higher proportion
of residents with less than 9 years of education appeared to
reduce the likelihood of breast cancer deaths. The hazard
ratio of ICE-Education comparing the poorest versus highest
group was 0.55 (95% CI, 0.31–0.98) and comparing the
middle versus highest group was 0.65 (95% CI, 0.44–0.96).
Furthermore, residing in a county with a higher proportion
of black residents (≥6%) significantly increased the likelihood
of breast cancer death (hazard ratio, 1.74; 95% CI, 1.21–2.48).
Facilities and Personnel variables did not appear to have
an independent significant effect on the likelihood of breast
cancer death after adjusting for other variables in the model.
Table 4 presents the results of the Cox Proportional Haz-
ardsmodels assessing the determinants of all-causemortality.
In contrast to the model predicting breast cancer survival
(Table 3), race remained a statistically significant predictor of
higher mortality among blacks compared to whites even after
adjusting for individual demographic and clinical variables.
In model 1 which adjusted for demographic variables, being
black was associated with a 38% increase in the likelihood
of death due to any cause compared with being white (95%
CI, 1.08–1.76). In model 2, the hazard ratio associated with
being black was 1.33 (95% CI, 1.04–1.70) after adjusting
for demographic and clinical variables. After adjusting for
county level variables in model 3, the effect of race was
attenuated and became nonsignificant (hazard ratio, 1.27;
95% CI, 0.95–1.71). Personnel, Facilities, county proportion
of blacks, and proportion of non-English speaking residents
were not significantly associated with all-cause mortality.
5. Discussion
In this study of black andwhite womenwith breast cancer, the
effect of race on breast cancer mortality became nonsignifi-
cant after adjusting for individual demographic variables. For
all-cause mortality, race was a significant predictor even after
adjusting for demographic and clinical variables such as stage
of presentation and treatment.
We observed sustained differences in the receipt of surgi-
cal and radiation treatment between black and white patients
in this study. This is particularly troubling given that these
treatment variables remained the most significant predictors
of breast cancer mortality and all-cause mortality even after
adjusting for individual and neighborhood level variables. It
has been suggested that the disparity in treatment receipt
among black women may be due to cultural factors which
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Table 2: Distribution of individual and county-level characteristics of breast cancer cases by race.
Characteristic Black (𝑁 = 216) % White (𝑁 = 1580) % 𝑃 value
Age at diagnosis mean (SD) 61.14 (14.34) 63.51 (13.49) 0.01








In labor force 49.91 47.66
Not in labor force 46.10 48.18 0.79
Missing 3.99 4.17
Education
<High school 23.57 9.51
High school graduate 29.99 38.76 <0.001
College 46.44 51.73
Rural/urban
Rural 6.22 9.15 0.12
Urban 93.78 90.85
Stage of diagnosis






None, medical reasons 4.30 2.06 0.03
None-non medical reasons 4.47 2.87
Radiation treatment
Received 31.17 38.61
None, medical reasons 62.42 55.68 0.07
None-nonmedical reasons 6.41 5.70
Income disparity
Poorest 36.94 16.77
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Table 2: Continued.






Personnel and facilities, two measures of health care access were defined using principal components analysis on the count per 10,000 population of county
level variables and then categorized into tertiles. Facilities: hospitals, mammography facilities; Personnel: MDs, Dos, and nurse practitioners.
bMeasures of SES at the county level are the ICE-Income and ICE-Education variables which were calculated and categorized into tertiles, defined as:
ICE-Education = (% 25+ years with college degree −% 25+ years with <9 yrs education).
ICE-Income = (% with HH income >$100,000 −%HH in poverty).
make them more likely to refuse treatment. However, in this
study we were able to distinguish between patients who did
not receive treatment due to medical reasons or nonmedical
reasons. Among women who did not receive treatment due
to medical reasons (implying that a medical personnel made
the decision not to treat), the proportion of black women was
still much higher. More research is urgently needed in this
area to better understand the factors that determine who gets
treatment.
Upon adjusting for county level healthcare access vari-
ables, race was no longer significantly associated with all-
cause mortality. Facilities and personnel variables did not
appear to have a significant independent effect on the like-
lihood of breast cancer or all-cause mortality after adjusting
for other variables in the model. Furthermore, residing in
counties with a higher proportion of households in poverty
increased the likelihood of breast cancer mortality and
all-cause mortality compared with counties with a higher
proportion of affluent households.
Our findings suggest that neighborhood poverty and lack
of healthcare resources to care might explain part of the
black-white disparity in breast cancer survival especially if
examined from both individual and neighborhood levels.
Many studies have sought to explain the causes of racial
disparities in breast cancer survival [10–13, 17, 23, 45–54],
with varying results. However, none of these studies assessed
the role of neighborhood healthcare resources in breast
cancer or all-cause survival although other studies have
been published about the impact of neighborhood healthcare
resources on stage at diagnosis [12, 33, 55]. Our study suggests
that stage at presentation is an important predictor of breast
cancer survival; late stage at diagnosis was associated with a
fourfold increase in the hazard of breast cancermortality after
adjusting for other variables. Studies that assessed the role of
county level healthcare access on late stage diagnosis of cancer
found that women residing in counties with fewer physicians
[33] and poor access to mammography facilities [32] were
more likely to have late stage cancer diagnosis. Other studies
have suggested that important predictors of mammography
use are having a primary care physician, travel times, and
public transportation hassles [55–64]. These are all factors
whichmay be compounded if there are inadequate healthcare
facilities and personnel within a county.
We anticipated that these county characteristics, number
of physicians, and mammography facilities would also be
associated with breast cancer survival through the availability
of early diagnosis and adequate treatment. However, our
measures of healthcare access did not independently predict
breast cancer survival, even though the initial racial disparity
in survival disappeared. This finding is consistent with a
recent publication which did not find an association between
the availability of medical resources and breast cancer mor-
tality at the county level [65]. Our finding may be due to
several factors. First is the geographic level at which the
neighborhood attributes are being measured. It is likely that
some heterogeneity in exposure (i.e., county SES and health-
care access) is lost by aggregating neighborhood measures
to the county level as opposed to the zip code or census
tract level. However, due to patient privacy concerns, the
SEER dataset does not routinely disclose patient geographic
location at levels smaller than the county. Second, this study
accounted for the availability of healthcare resources but not
accessibility. However, the concept of healthcare access is
very complex and multidimensional, incorporating aspects
of availability such as the presence of medical facilities and
personnel as well as aspects of accessibility such as distance,
affordability, and cultural barriers. This study serves as a first
step in understanding the role of one aspect of healthcare
access on breast cancer survival, and future studies may build
on this research to further improve understanding of other
aspects.
Third, other neighborhood level factors such as racial or
economic segregation may also be important in understand-
ing racial differences in breast cancer survival and need to
be examined. For instance, we found that women residing in
counties with a higher proportion of blacks had significantly
higher hazards of breast cancer mortality. This is especially
relevant to this study of racial disparities because studies have
shown that due to lower income levels on average, blacks are
more likely to reside in poor counties [26, 32]. However, due
to established social and family networks, even blacks that
belong to higher SES groups are more likely to continue to
reside in these poor counties. This has implications for the
understanding of the impact of socioeconomic status and
breast cancer survival among blacks, because black women
earning higher incomes may not benefit as much from their
socioeconomic status as white women earning similar wages
but residing in high SES counties.
We observed a significant increase hazard of breast
cancer and all-cause mortality due to neighborhood income.
Women residing in counties with a higher proportion of low
income residents compared with high income residents had
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Table 3: Cox Proportional Hazard analysis of breast cancer mortality, SEER-NLMS, 1973–2003.
Characteristics







Black 1.53 (1.11–2.11)∗∗ 1.40 (0.99–1.97) 1.40 (0.99–1.98) 1.32 (0.73–2.41)
White (ref.) 1.00 1.00 1.00 1.00
Age 1.02 (1.01-1.02)∗∗ 1.01 (1.00–1.02) 1.01 (0.99–1.02) 1.01 (0.99–1.02)
Income/$1000 0.99 (0.99-1.00)∗ 0.99 (0.99-1.00) 0.99 (0.99–1.00) 0.99 (0.99–1.00)
Employed
Not in labor force 1.09 (0.87–1.38) 1.02 (0.78–1.33) 1.33 (1.01–1.74)∗ 1.38 (0.89–2.14)
In labor force (ref.) 1.00 1.00 1.00 1.00
Marital status
Single 1.35 (0.90–2.03) 1.10 (0.72–1.70) 1.21 (0.78–1.87) 1.16 (0.67–2.02)
Divorced/separated 1.57 (1.12–2.19) 1.43 (1.01–2.03)∗ 1.57 (1.09–2.25)∗ 1.64 (1.09–2.45)∗
Widowed 1.05 (0.79–1.38) 0.95 (0.71–1.28) 1.09 (0.80–1.48) 1.09 (0.72–1.66)
Married (ref.) 1.00 1.00 1.00 1.00
Education
<High school 1.68 (1.19–2.36)∗∗ 1.44 (1.00–2.05)∗ 1.36 (0.95–1.94) 1.35 (0.99–1.85)
High school grad 1.43 (1.12–1.83)∗∗ 1.38 (1.08–1.78)∗ 1.42 (1.09–1.83)∗∗ 1.55 (1.22–1.96)∗∗



















None-non medical reasons 5.07 (3.36–7.60)∗∗ 3.72(2.39–5.84)∗∗∗ 3.23 (1.56–6.68)
∗∗
Received (ref.) 1.00 1.00 1.00
Radiation treatment
None-autopsy diagnosis 1.05 (0.82–1.35) 0.87 (0.67–1.41) 0.85 (0.62–1.16)
None-refused/unknown 2.57 (1.68–3.91)∗∗ 2.10 (1.35–3.28)∗∗ 1.91 (0.95–3.86)
Received (ref.) 1.00 1.00 1.00
Rural/urban
Urban 1.12 (0.74–1.69) 1.40 (0.84–2.35)∗
Rural (ref.) 1.00 1.00
dIncome disparity
Poorest 1.24 (0.96–1.61) 1.29 (0.82–2.05)
Middle 1.17 (0.86–1.59) 1.49 (1.12–1.99)∗∗
Highest (ref.) 1.00 1.00
dEducation disparity
Poorest 1.03 (0.74–1.43) 0.55 (0.31–0.98)∗
Middle 1.03 (0.77–1.39) 0.65 (0.44–0.96)∗
Highest (ref.) 1.00 1.00
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Table 3: Continued.
Characteristics







Poorest 0.76 (0.59–0.97) 1.01 (0.61–1.68)
Middle 1.00 (0.77–1.31) 1.15 (0.66–1.99)
Highest (ref.) 1.00 1.00
ePersonnel
Poorest 1.12 (0.78–1.61) 0.78 (0.40–1.51)
Middle 0.96 (0.72–1.27) 0.78 (0.49–1.24)
Highest (ref.) 1.00 1.00
Proportion non-English
speaking
≥3% 0.75 (0.59–0.95)∗ 0.91 (0.56–1.48)
<3% (ref.) 1.00 1.00
Proportion black
≥6% 1.29 (0.98–1.68) 1.74 (1.21–2.48)∗∗
<6% (ref.) 1.00 1.00
∗
𝑃 < 0.05, ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001; CI: confidence interval; ref: reference group.
aModel adjusting for individual demographic variables only.
bModel adjusting for clinical variables such as stage at presentation and treatment in addition to demographic variables.
cModel adjusting for county level variables including healthcare access and SES in addition to individual demographics and clinical variables.
dMeasures of SES at the county level are the ICE-Income and ICE-Education variables which were calculated and categorized into tertiles, defined as
ICE-Education = (% 25+ years with college degree −%25+ years with <9 yrs education).
ICE-Income = (% with HH income > $100,000 −%HH in poverty).
ePersonnel and facilities, two measures of health care access were defined using principal components analysis on the count per 10,000 population of county
level variables and then categorized into tertiles. Facilities: hospitals, mammography facilities; Personnel: MDs, Dos, and nurse practitioners.
higher hazards. This is consistent with other studies using
other definitions of county SES [20, 23, 66, 67]. However, we
also observed significant reduction in the hazard of breast
cancer and all-cause mortality for counties with a higher
proportion of less educated residents. This observation was
unexpected especially since higher individual education level
was found to be protective in this study as well as in others
[24, 37, 66, 68]. One explanation for this finding may be the
small sample size in counties with a higher proportion of less
educated residents. Another potential explanation is the high
proportion of immigrants whomay be less educated butmore
likely to have close-knit social networks that has been found
to be protective against adverse health outcomes [69].
The major strength of this study was the availability of
individual SES information for cancer patients. This allowed
for better control of potential confounding of the associa-
tion between neighborhood characteristics and survival by
individual SES. Another strength is the development of a
specificmeasure of neighborhood healthcare access using the
availability of healthcare resources including mammography
facilities to better capture factors that may affect early detec-
tion which is a major determinant of survival.
There are several limitations of our study. First, there
is a possibility of exposure misclassification bias because
measures of individual SES (household income, education,
and employment) were not obtained at the time of diagnosis
with cancer. These measures were obtained through surveys
which may have been administered before or after cancer
diagnosis. However, our analysis was restricted to breast
cancer cases ages 40 and older, reducing the likelihood of
dramatic changes in SES through the study period. Secondly,
our measure of healthcare access at the county level is an
indicator of availability, not necessarily accessibility. Several
other factors may determine if a person actually benefits
from living in a county with good healthcare facilities such as
language or cultural barriers, mistrust of the medical system,
and lack of health insurance. Thirdly, for analytical reasons,
the study samplewas restricted towomen residing in counties
that had at least one black and one white breast cancer
patients.This implies that the populationmay be more urban
compared with the rest of the US. However, the results of
this analysis may still be applicable to semi-urban or rural
areas where the impact of county SES and healthcare access
on breast cancer survival may be even more pronounced.
We performed a sensitivity analysis using only white
women (𝑛 = 1580) and found similar results; the neigh-
borhood variables did not significantly predict breast cancer
survival among white women. However they did attenuate
the effect of stage and treatment on survival. This supports
our earlier conclusion that the county level variables may
influence breast cancer survival (for both white and black
women) through the availability of screening and timely
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Table 4: Cox Proportional Hazard analysis of all-cause mortality, SEER-NLMS, 1973–2003.
Characteristics







Black 1.32 (1.05–1.66)∗ 1.38 (1.08–1.76)∗∗ 1.33 (1.04–1.70)∗ 1.27 (0.95–1.71)
White (ref.) 1.00 1.00 1.00 1.00
Age 1.06 (1.05-1.06)∗∗∗ 1.05(1.04–1.06)∗∗∗ 1.05 (1.04-1.05)
∗∗∗ 1.05 (1.03–1.06)∗∗∗
Income/$1000 0.99(0.98-0.99)∗∗∗ 0.99 (0.99-1.00) 0.99 (0.99-1.00) 0.99 (0.99-1.00)
Employed
Not in labor force 1.60(1.36–1.88)∗∗∗ 1.0 (0.83–1.21) 1.18 (0.98–1.43) 1.18 (0.92–1.51)
In labor force (ref.) 1.00 1.00 1.00 1.00
Marital status
Single 1.48 (1.11–1.97)∗∗∗ 1.32 (0.97–1.78) 1.44 (1.06–1.95)∗ 1.40 (0.95–2.06)
Divorced/separated 1.39(1.08–1.79)∗∗∗ 1.39 (1.07–1.81)
∗ 1.58 (1.21–2.07)∗∗ 1.59 (1.19–2.14)∗∗
Widowed 1.70 (1.43–2.02)∗∗ 1.16 (0.96–1.39) 1.29 (1.07–1.57)∗∗ 1.36 (1.01–1.83)∗
Married (ref.) 1.00 1.00 1.00 1.00
Education
<High school 1.95 (1.56–2.42)∗∗ 1.49 (1.19–1.87)∗∗ 1.44 (1.14–1.79)∗∗ 1.41 (1.05–1.89)∗
High school grad 1.32 (1.12–1.56)∗∗∗ 1.23 (1.04–1.46)∗ 1.28 (1.08–1.52)∗∗ 1.34 (1.10–1.64)∗∗






Distant/unstaged 3.29(2.71–4.02)∗∗∗ 1.87 (1.51–2.30)
∗∗∗ 2.16 (1.55–3.02)∗∗∗












Received (ref.) 1.00 1.00 1.00
Radiation treatment
None-medical reasons 1.25(1.05–1.49)∗∗∗ 0.96 (0.79–1.15) 0.95 (0.77–1.18)
None-non medical reasons 2.46(1.80–3.35)∗∗∗ 2.23 (1.61–3.09)
∗∗ 2.10 (1.46–3.03)∗∗∗
Received (ref.) 1.00 1.00
Rural/Urban
Urban 1.29 (0.96–1.74) 1.28 (0.87–1.88)
Rural (ref.) 1.00 1.00
dIncome disparity
Poorest 1.27 (1.05–1.53)∗∗ 1.37 (1.03–1.82)∗
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Table 4: Continued.
Characteristics






Middle 1.12 (0.88–1.41) 1.27 (1.03–1.58)∗
Highest (ref.) 1.00 1.00
dEducation Disparity
Poorest 1.06 (0.82–1.39) 0.61 (0.47–0.81)∗∗
Middle 1.10 (0.87–1.39) 0.75 (0.60–0.93)∗∗
Highest (ref.) 1.00 1.00
eFacilities
Poorest 0.82(0.69–0.98)∗∗ 0.98 (0.68–1.41)
Middle 1.12 (0.90–1.40) 1.13 (0.79–1.64)
Highest (ref.) 1.00 1.00
ePersonnel
Poorest 1.09 (0.81–1.47) 0.93 (0.64–1.36)
Middle 1.09 (0.87–1.36) 0.98 (0.79–1.21)
Highest (ref.) 1.00 1.00
Proportion non-English
speaking
>3% 0.76(0.63–0.93)∗∗ 0.87 (0.63–1.19)
<3% (ref.) 1.00 1.00
Proportion black
>6% 1.01 (0.82–1.25) 1.19 (0.97–1.47)
<6% (ref.) 1.00 1.00
∗
𝑃 < 0.05, ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001; CI: confidence interval; ref: reference group
aModel adjusting for individual demographic variables only.
bModel adjusting for clinical variables such as stage at presentation and treatment in addition to demographic variables.
cModel adjusting for county level variables including healthcare access and SES in addition to individual demographics and clinical variables.
dMeasures of SES at the county level are the ICE-Income and ICE-Education variables which were calculated and categorized into tertiles, defined as
ICE-Education = (% 25+ years with college degree −% 25+ years with <9 yrs education).
ICE-Income = (% with HH income > $100,000 −%HH in poverty).
ePersonnel and Facilities, two measures of health care access were defined using principal components analysis on the count per 10,000 population of county
level variables and then categorized into tertiles. Facilities: hospitals, mammography facilities; Personnel: MDs, Dos, and nurse practitioners.
treatment. The differential impact of these county variables
whichmay contribute to the racial disparities in breast cancer
survival between black and white women (effect measure
modification) was assessed through interaction terms in the
final model; however there were no significant interactions
possibly due to the low sample size of black women within
each group.
Finally, we performed a post hoc power analysis to assess
the statistical power of the study to detect a statistically
significant difference between breast cancer survival in black
andwhite women.Given the sample size of 216 black and 1580
white patients, type 1 error rate of 0.05, and a followup of 30
years, the study had a power level of 85%.This implies that if a
difference in races existed, we had an 85% chance of detecting
it.
In summary, our study adds an important component
to the existing evidence on survival disparities by concep-
tualizing healthcare access at the county level as a potential
determinant of health outcomes and as a potential modifier
of the association between race andmortality. Further studies
may focus on defining healthcare access at smaller geographic
levels, for example, zip code or census tracts which may be
more homogenous in the distribution of healthcare facilities
and personnel. Furthermore, while our study focused on the
quantity of healthcare facilities and personnel, other studies
may attempt to include a measure of healthcare quality
as another measure of healthcare access and a potential
determinant of survival.
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